Tech Company Financing Transactions
DefEYE Funding Round
On 11/6/2025, DefEYE announced funding from ExSight Ventures.
Transaction Overview
Company Name
Announced On
11/6/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
ExSight Ventures (Firas Rahhal)
Proceeds Purpose
The funding will enable DefEYE to accelerate commercialization through continued growth and expansion.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New York, NY Undisclosed
USA
New York, NY Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
DefEYE, Inc. is a rapidly growing ocular company on a mission to transform and personalize therapeutic approaches in eye care. DefEYE uses decellularized placental-based tissue to redefine the ocular biologics landscape with an innovative approach to both ocular surface disease and ocular surgical management.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rob Sambursky
Browse more venture capital transactions:
Prev: 11/6/2025: Amae Health venture capital transaction
Next: 11/6/2025: Arx Research venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs